APCO has appointed South Africa-based Infinitum Global Health (IGH) as its regional partner to...
MEDEZE Targets THB1 Billion Revenue in 2026 on ATMPs and Stem Cell Innovations
Dr. Veerapol Khemarangsan, Managing Director of Medeze Group Public Company Limited (SET: MEDEZE), revealed...
MEDEZE Sets Ambitious Growth Goals, Eyes Thailand as Medical and Wellness Hub
Dr. Veerapol Khemarangsan, M.D., Chief Executive Officer of MEDEZE Group Public Company Limited (SET:...
MEDEZE Celebrates 15th Anniversary, Driving Thailand Health Economy with Stem Cell Technology
Dr. Veerapol Khemarangsan, Chief Executive Officer of MEDEZE Group Public Company Limited (SET: MEDEZE),...
Broker Prices MEDEZE at THB8.60 as Trend for Stem Cell Boost Growth Outlook
Analysts at Daol Securities (Thailand) maintain a "Buy" recommendation for MEDEZE Group Plc. (SET:...
Southeast Asia Stem Cell Leader Medeze Launches Partial Offer for 10% Stake in SGX-listed Cordlife Group
Offer price of S$0.25 per share is at an attractive premium of 61.3% over...